Difference between revisions of "Effect of development of health care system in emerging market countries to existing pharmaceutical industry"
Jump to navigation
Jump to search
Line 7: | Line 7: | ||
==Enablers:== | ==Enablers:== | ||
WHO | |||
India medical development | |||
==Inhibitors:== | ==Inhibitors:== | ||
Factors which weaken this driving force. (these are actually other driving forces, and you can link to them in the wiki!) | Factors which weaken this driving force. (these are actually other driving forces, and you can link to them in the wiki!) |
Revision as of 20:05, 16 September 2009
This page is under construction and edited by Susan Liu EMBA09. In case of any questions/remarks, feel free to contact me
Description:
Generic durgs will be mainstream. Western pharmaceutical companies no longer can hold on to their patent with current business model.
Enablers:
WHO
India medical development
Inhibitors:
Factors which weaken this driving force. (these are actually other driving forces, and you can link to them in the wiki!)
Paradigms:
Changes in ways of thinking about the world due to the driving force.
Experts:
Sources for additional information about this driving force. (if you have found people, put the links to them)
Timing:
Dates for key milestones in the development of the driving force.
Web Resources:
Useful resources on the web relating to this force.